We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARDX icon
1676
Ardelyx
ARDX
$1.25B
$2.12M ﹤0.01%
743,407
+631,607
+565% +$1.07M
PLNT icon
1677
Planet Fitness
PLNT
$4.43B
$2.11M ﹤0.01%
26,833
-21,497
-44% -$1.5M
CSV icon
1678
Carriage Services
CSV
$648M
$2.11M ﹤0.01%
76,566
-9,340
-11% -$254K
MAQCW
1679
CALL
DELISTED
Maquia Capital Acquisition Corporation Warrant
MAQCW
$2.08M ﹤0.01%
200,000
-199,568
-50% -$9.18K
EAT icon
1680
Brinker International
EAT
$8.5B
$2.08M ﹤0.01%
65,150
+21,718
+50% +$683K
SNAP icon
1681
CALL
Snap
SNAP
$8.02B
$2.08M ﹤0.01%
232,100
RTP.WS
1682
CALL
DELISTED
Reinvent Technology Partners Redeemable Warrants, each whole warrant exercisable for one Class A ord
RTP.WS
$2.08M ﹤0.01%
620,083
PLAO
1683
DELISTED
Patria Latin American Opportunity Acquisition Corp. Class A Ordinary Shares
PLAO
$2.08M ﹤0.01%
199,998
DIN icon
1684
Dine Brands
DIN
$458M
$2.07M ﹤0.01%
+32,099
New +$2.23M
LGVCW
1685
CALL
DELISTED
LAMF Global Ventures Corp. I Warrant
LGVCW
$2.07M ﹤0.01%
202,288
TOACW
1686
CALL
DELISTED
Talon 1 Acquisition Corp. Warrant
TOACW
$2.07M ﹤0.01%
200,000
IVCB
1687
DELISTED
Investcorp Europe Acquisition Corp I Class A Ordinary Shares
IVCB
$2.06M ﹤0.01%
200,398
NOG icon
1688
Northern Oil and Gas
NOG
$2.16B
$2.06M ﹤0.01%
66,892
+57,692
+627% +$1.94M
ASBPW
1689
CALL
Aspire Biopharma Warrant
ASBPW
$579K
$2.06M ﹤0.01%
199,998
EQX icon
1690
Equinox Gold
EQX
$7.22B
$2.06M ﹤0.01%
+627,457
New +$2.16M
FAASW
1691
CALL
DELISTED
DigiAsia Corp Warrant
FAASW
$2.06M ﹤0.01%
199,995
ABR icon
1692
Arbor Realty Trust
ABR
$979M
$2.05M ﹤0.01%
155,656
-474,044
-75% -$6.44M
DPCSW
1693
CALL
DELISTED
DP Cap Acquisition Corp I Warrants
DPCSW
$2.05M ﹤0.01%
200,000
SCUA.WS
1694
CALL
DELISTED
Sculptor Acquisition Corp I Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SCUA.WS
$2.05M ﹤0.01%
199,997
CPAQ
1695
DELISTED
Counter Press Acquisition Corporation Class A Ordinary Share
CPAQ
$2.05M ﹤0.01%
199,996
JBHT icon
1696
JB Hunt Transport Services
JBHT
$26.1B
$2.05M ﹤0.01%
11,761
-152,981
-93% -$26.7M
SGHL
1697
DELISTED
Signal Hill Acquisition Corp. Class A Common Stock
SGHL
$2.05M ﹤0.01%
200,176
BRD.WS
1698
CALL
DELISTED
Beard Energy Transition Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
BRD.WS
$2.04M ﹤0.01%
200,000
CASY icon
1699
Casey's General Stores
CASY
$31.7B
$2.04M ﹤0.01%
9,083
-27,450
-75% -$6.25M
FIACW
1700
CALL
DELISTED
Focus Impact Acquisition Corp. Warrant
FIACW
$2.04M ﹤0.01%
200,000

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.